In today’s competitive global environment, universities play an important role in inspiring diversity among new generations of entrepreneurs and innovators to improve the innovation ecosystem. Providing underrepresented researchers with access to opportunities and networks can bring the needed change to better reflect the diversity of our nation and to tip the scale toward equity and inclusion in innovation.
A new state-of-the-art brain-imaging scanner for advanced exploration into the workings of the human brain - a Siemens PRISMA functional magnetic resonance imaging (fMRI) scanner - will soon be available to researchers at the Rutgers University Brain Imaging Center thanks to a National Science Foundation grant in combination with matching funds from Rutgers University.
Rutgers University was selected as one of five new hubs under the NIH’s Research Evaluation and Commercialization Hubs (REACH) program to speed up the translation of biomedical discoveries into commercially viable diagnostics, devices, therapeutics, and tools to improve patient care, enhance health, and train the next generation of innovators.
Rutgers' Senior Vice President for Research and Economic Development issues statement in support of researchers participating in #ShutDownSTEM to actively support the ongoing Black Lives Matter movement and efforts against racism in the scientific community and society.
Rutgers University and professional services company Accenture join efforts to solve the necessity of face shields and other personal protection equipment for healthcare workers and researchers on the front lines of the COVID-19 pandemic.
HealthAdvance™ announces its inaugural award to advance the commercialization of anti-cancer therapeutics being developed by researchers Raymond B. Birge from New Jersey Medical School and William Welsh from Robert Wood Johnson Medical School, in collaboration with Youyi Peng at the Rutgers Cancer Institute of New Jersey.
A milestone patent for a rapid, automated test for detecting Mycobacterium tuberculosis (TB) and Rifampicin-resistant M. tuberculosis invented by two Rutgers University researchers received the 2019 Edison Patent Award from the Research & Development Council of New Jersey.